Expression and biological activity of lytic proteins HolST-3 and LysST-3 of Salmonella phage ST-3.
Antibiotic resistance
HolST-3
LysST-3
Protein expression
Zebrafish
Journal
Microbial pathogenesis
ISSN: 1096-1208
Titre abrégé: Microb Pathog
Pays: England
ID NLM: 8606191
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
31
03
2022
revised:
05
06
2022
accepted:
08
06
2022
pubmed:
14
6
2022
medline:
10
8
2022
entrez:
13
6
2022
Statut:
ppublish
Résumé
Salmonella infection is a major public health concern. Several strategies for Salmonella infection prevention and control are currently available including vaccines and antibiotics. However, vaccines are expensive and inefficient, and the use of antibiotics can lead to antibiotic resistance. Thus, alternative strategies for the treatment of Salmonella remain warrant. In this study, recombinant holin HolST-3 and lysin LysST-3 from Salmonella phage ST-3 were expressed and purified, and their bactericidal properties were analyzed. HolST-3 and LysST-3 possessed a wider lysis spectrum and more efficient bactericidal effect than phage ST-3, and a synergistic bactericidal effect was observed when combined in vitro. In addition, we explored the bactericidal properties of HolST-3 and LysST-3 in vivo using zebrafish as a model organism, and found that the bactericidal effects of both HolST-3 and LysST-3 in vivo were comparable to those of cefotaxime, an antibiotic. This study provides a basis for the development of HolST-3 and LysST-3 as novel bactericidal agents for the prevention and treatment of infectious diseases caused by Salmonella spp.
Identifiants
pubmed: 35697172
pii: S0882-4010(22)00237-6
doi: 10.1016/j.micpath.2022.105624
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105624Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.